KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Equity: 2019-2025

Historic Return on Equity for Castle Biosciences (CSTL) over the last 6 years, with Sep 2025 value amounting to -0.03%.

  • Castle Biosciences' Return on Equity fell 4.00% to -0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.04% for FY2024, which is 19.00% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Return on Equity is -0.03%, which was down 25.62% from -0.02% recorded in Q2 2025.
  • Castle Biosciences' Return on Equity's 5-year high stood at 0.04% during Q4 2024, with a 5-year trough of -0.23% in Q2 2023.
  • Moreover, its 3-year median value for Return on Equity was -0.03% (2025), whereas its average is -0.08%.
  • As far as peak fluctuations go, Castle Biosciences' Return on Equity declined by 12bps in 2021, and later rose by 23bps in 2024.
  • Quarterly analysis of 5 years shows Castle Biosciences' Return on Equity stood at -0.08% in 2021, then fell by 9bps to -0.17% in 2022, then climbed by 2bps to -0.15% in 2023, then rose by 19bps to 0.04% in 2024, then dropped by 4bps to -0.03% in 2025.
  • Its Return on Equity was -0.03% in Q3 2025, compared to -0.02% in Q2 2025 and -0.01% in Q1 2025.